tirzepatide optic neuropathy The popular #diabetes and weight loss medication #tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic #retinopathy, a leading cause of vision loss, according to Dr. Szilárd Kiss and Wegovy May Carry Highest Risk

That figure drops meaningfully as intake increases

Why GLP-3 Hasnt Gained Traction Lack of Clinical Data: Without clear receptors and mechanisms, its challenging to develop therapeutic applications

Most clinical trials on humans use doses between 500 mg and 1,500 mg, which researchers have found to be safe for adults

This pilot study demonstrated that this is a viable alternative during a time when semaglutide for weight loss is not commercially readily available

Common step therapy requirements for Ozempic in 2026 include trying: If youve already been on one of these medications and it was ineffective or caused adverse effects, document this clearly with your doctor